Europe Helicobacter Pylori Non-invasive Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

Description

List of Tables

The helicobacter pylori (H. pylori) non-invasive testing market in Europe is expected to grow from US$ 198.40 million in 2022 to US$ 244.01 million by 2028; it is estimated to grow at a CAGR of 3.5% from 2022 to 2028.

Awareness Among Individuals Regarding Diagnosis of H. pylori Fuel Europe Helicobacter Pylori (H. pylori)

Diagnosis of H. pylori infection is performed by invasive (endoscopy and endoscopic biopsy for histopathology, culture, and rapid urease test) and non-invasive (urea breath tests, stool antigen test, and serological tests) methods. The diagnostic decisions are based on the prevalence of H. pylori infection and the number of incidences of age-related gastric cancer. For instance, non-invasive techniques are preferred mostly when the incidence of gastric cancer is low. However, endoscopy is recommended for patients who have a high probability of being diagnosed with gastric cancer, such as patients above 60 years of age or younger patients in a few European countries, or patients with a family history of gastric cancer, or countries with a high incidence of gastric cancer. Further, precise accuracy is obtained by using multiple diagnostic tests. Although these tests have high accuracy, endoscopy-based diagnostic methods are not recommended for screening purposes, mainly due to their invasiveness, high cost, and unavailability. However, in a few European countries, endoscopy is recommended for patients over the age of 45 years who have a high chance of developing gastric cancer. Thus, governments of various European countries are boosting awareness of the diagnosis of H. pylori, which is expected to fuel the market growth.

Further, in 2020, RedHill Biopharma launched a nationwide H. pylori disease state educational field led by its sales team. The launch is intended to provide greater awareness to healthcare professionals regarding the risk of H. pylori infection and the growing resistance of H. pylori to standard care of antibiotics, which leads to 25-40% failure of current therapies.

Market Overview

As per the Elsevier B.V. report, H. pylori infects ~25% of the German population and causes gastritis that becomes more complicated with peptic ulcer disease, gastric adenocarcinoma, or mucosa-associated lymphoid tissue (MALT) lymphoma annually. According to the National Institute of Health (NIH) report, H. pylori infection causes chronic inflammation that significantly increases the risk of developing duodenal and gastric ulcer disease and gastric cancer. Additionally, H. pylori infection is the strongest known risk factor for gastric cancer and is the second-leading cause of cancer-related deaths globally. As per the same report, ~15,500 people annually have gastric cancer, with a decreasing number of incidences and a 5-year survival rate of 30-35%. Moreover, Germany has no gastric cancer prevention programs, resulting in the disease being diagnosed frequently in locally advanced stages. Such aforementioned factors are responsible for the growth of the Helicobacter pylori (H. pylori) non-invasive testing market.

Europe Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)

Europe Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation

The Europe helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country.

Based on test type, the Europe Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market. Based on test method, the Europe Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022. Based on end user, the Europe Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022. Based on country, the market is segmented into France, Germany, Italy, the UK, Spain, and the Rest of Europe. Further, Germany dominated the market in 2022. Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in Europe.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe helicobacter pylori (H. pylori) non-invasive testing market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe helicobacter pylori (H. pylori) non-invasive testing market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the helicobacter pylori (H. pylori) non-invasive testing market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00027543

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - By Test Type
- 1.3.2 Europe Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By Test Method
- 1.3.3 Europe Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By End User
- 1.3.4 Europe Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion

5. Europe Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing prevalence of H. pylori bacterial infection
- 5.1.2 New Product Launches & FDA Approvals for Noninvasive Tests
- 5.1.3 Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori
- 5.1.4 Rise in Investments by Pharmaceutical Companies
5.2 Key Market Restraints
- 5.2.1 Low Diagnosis Rate
5.3 Key Market Opportunities
- 5.3.1 Increasing Number of Conferences and Events for Research
- 5.3.2 Introduction of Artificial Intelligence
5.4 Future Trends
- 5.4.1 Increasing Use of Home-Based POC Devices
- 5.4.2 Diagnosis for Resistance
5.5 Impact Analysis

6. Helicobacter pylori (H. pylori ) Non-Invasive Testing Market- Europe Analysis

6.1 Europe Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis

7. Europe Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis- by Test Type

7.1 Overview
7.2 Europe Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)
7.3 Serology Test
- 7.3.1 Overview
- 7.3.2 Europe Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Stool Antigen Test
- 7.4.1 Overview
- 7.4.2 Europe Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Urea Breath Test
- 7.5.1 Overview
- 7.5.2 Europe Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)

8. Europe Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis- by Test Method

8.1 Overview
8.2 Europe Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)
8.3 Laboratory Based Tests
- 8.3.1 Overview
- 8.3.2 Europe Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 Point Of Care Tests
- 8.4.1 Overview
- 8.4.2 Europe Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)

9. Europe Helicobacter pylori (H. pylori ) Non-invasive Testing Market Analysis- by End User

9.1 Overview
9.2 Europe Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By End User 2018 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Europe Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Clinics
- 9.4.1 Overview
- 9.4.2 Europe Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Europe Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

10. Europe Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 - Country Analysis

10.1 Overview
- 10.1.1 Europe: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
  - 10.1.1.1 Germany: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 Germany: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 Germany: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.4 Germany: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.5 Germany: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.2 France: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 France: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 France: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.4 France: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.5 France: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.3 UK: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 UK: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 UK: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.4 UK: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.5 UK: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.4 Italy: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Italy: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.3 Italy: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.4 Italy: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.5 Italy: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.5 Spain: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Spain: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.3 Spain: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.4 Spain: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.5 Spain: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.6 Rest of Europe: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Europe: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.4 Rest of Europe: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.5 Rest of Europe: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)

11. Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profile

12.1 DiaSorin S.p.A.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Meridian Bioscience, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 QuidelOrtho Corporation
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Abbott Laboratories
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 CerTest Biotec
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Sekisui Diagnostics
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Coris BioConcept
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Bio-Rad Laboratories, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms